Research Article

Open Access
Harnessing reaction-based probes to preferentially target pancreatic β-cells and β-like cells
View ORCID ProfileSevim Kahraman, Debasish Manna, View ORCID ProfileErcument Dirice, Basudeb Maji, Jonnell Small, View ORCID ProfileBridget K Wagner, View ORCID ProfileAmit Choudhary Correspondence email, View ORCID ProfileRohit N Kulkarni Correspondence email
Sevim Kahraman
1Islet Cell and Regenerative Biology, Joslin Diabetes Center, Department of Medicine, Brigham and Women’s Hospital, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA
Debasish Manna
2Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA
3Department of Medicine, Harvard Medical School, Boston, MA, USA
4Divisions of Renal Medicine and Engineering, Brigham and Women’s Hospital, Boston, MA, USA
Ercument Dirice
1Islet Cell and Regenerative Biology, Joslin Diabetes Center, Department of Medicine, Brigham and Women’s Hospital, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA
Basudeb Maji
2Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA
3Department of Medicine, Harvard Medical School, Boston, MA, USA
4Divisions of Renal Medicine and Engineering, Brigham and Women’s Hospital, Boston, MA, USA
Jonnell Small
2Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA
5Chemical Biology Program, Harvard University, Cambridge, MA, USA
Bridget K Wagner
2Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA
Amit Choudhary
2Chemical Biology and Therapeutics Science Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA
3Department of Medicine, Harvard Medical School, Boston, MA, USA
4Divisions of Renal Medicine and Engineering, Brigham and Women’s Hospital, Boston, MA, USA
5Chemical Biology Program, Harvard University, Cambridge, MA, USA
Rohit N Kulkarni
1Islet Cell and Regenerative Biology, Joslin Diabetes Center, Department of Medicine, Brigham and Women’s Hospital, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA
Published 29 January 2021. DOI: 10.26508/lsa.202000840

Developing approaches to target β-cells
Sevim Kahraman, Debasish Manna, Ercument Dirice, Basudeb Maji, Jonnell Small, Bridget K Wagner, Amit Choudhary, Rohit N Kulkarni
Life Science Alliance Jan 2021, 4 (4) e202000840; DOI: 10.26508/lsa.202000840
In this Issue
Volume 4, No. 4
April 2021
Advertisement
Jump to section
Subjects
Related Articles
- No related articles found.
Cited By...
- No citing articles found.